Director/PDMR Shareholding

GSK PLC

26 March 2024

 

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sally Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The sale of 3,551 Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £16.8719 3,551
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date of the transaction	2024-03-25
f)	Place of the transaction	London Stock Exchange (XLON)

 

END